The use of positive B cell flow cytometry crossmatch in predicting rejection among renal transplant recipients

Clinical Transplantation

Volumn 13, Issue 1 II, 1999, Pages 83-89

  Kotb, Malak ^a   Russell, Wendy C ^a   Hathaway, Donna K ^a   Gaber, Lillian W ^a   Gaber, A Osama ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

B cell; Flow crossmatch; Renal transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY;

B LYMPHOCYTE; CONFERENCE PAPER; DEVICE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; HUMAN; HUMAN CELL; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIZATION; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 0032983642     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.1999.130104.x     Document Type: Conference Paper

References (26)

1. GAROVOY MR, RHEINSCHMIDT MA, BIGOS M et al. Flow cytometry analysis: a high technology crossmatch technique facilitating transplantation. Transplant Proc 1983: 15: 1939.
2. THISTLETHWAITE JR JR, BUCKINGHAM MR, STUART JK, STUART FP. Detection of presensitization in renal allograft recipients using a flow cytometric immunofluorescence crossmatch. Transplant Proc 1986: 18: 676.
3. LAZDA VA. Identification of patients at risk for inferior renal allograft outcome by a strongly positive B cell flow cytometry crossmatch. Transplantation 1994: 57: 964.
4. OGURA K, TERASAKI PI, JOHNSON C et al. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation. Transplantation 1993: 56: 294.
5. THISTLETHWAITE JR JR, BUCKINGHAM MR, GABER AO, STUART JK, STUART FP. Correlation of the outcome of renal transplantation with T cell flow cytometric immunofluorescence crossmatch results. Transplant Proc 1986: 18: 440.
6. BERTELI AJ, DANIEL V, POMERS S, OPELZ G. Clinical relevance of pretransplant flow cytometric crossmatches with T and B lymphocytes in kidney transplantation. Transplant Proc 1990: 22: 1895.
7. TALBOT D, CAVANAGH G, COATES E et al. Improved graft outcome and reduced complications due to flow cytometric crossmatching and DR matching in renal transplantation. Transplantation 1992: 53: 925.
8. TALBOT D. The flow cytometric crossmatch in perspective. Transplant Immunol 1993: 1: 155.
9. SCORNIK JC, BRUNSON ME, SCHAUB B, HOWARD RJ, PFAFF WW. The crossmatch in renal transplantation. Transplantation 1994: 57: 621.
10. IWAKI Y, COOK DJ, TERASAKI PI et al. Flow cytometry crossmatching in human cadaver kidney tranplantation. Transplant Proc 1987: 19: 764.
11. CHAPMAN JR, DEIERHOI MH, CARTER NP, TING A, MORRIS PJ. Analysis of flow cytometry and cytotoxicity crossmatches in renal transplantation. Transplant Proc 1985: 17: 2480.
12. MAHONEY RJ, NORMAN DJ, COLOMBE BW, GAROVOY MR, LEEBER DA. Identification of high-and low-risk second kidney grafts. Transplantation 1996: 61: 1349.
13. KERMAN RH, VAN BUREN CT, LEWIS RM et al. Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients. Transplantation 1990: 49: 52.
14. LEFOR WM, ACKERMANN JRW, ALVERANGA DY et al. Flow cytometry crossmatching and primary cadaver kidney graft outome: relevance of T and B cell targets, historic sera, and autologus controls. Clin Transplant 1996: 10: 601.
15. ALLOWAY R, KOTB M, GABER LW, VERA S, BOSKEY F, GABER AO. Standard versus low-dose OKT3 induction therapy of cadaveric renal transplants: comparison of outcome data versus OKT3 dose and serum levels. Clin Transplant 1992: 46: 468.
16. FIRST MR, SCHROEDER TJ, MICHAEL A et al. Cyclosporine-ketoconazole interaction: long-term follow-up and preliminary results of a randomized trial. Transplantation 1993: 55: 1000.
17. BRYAN CF, AEDER MI, HELLING TS, LUGER AM, NELSON PW, PIERCE GE. Clinical relevance of a positive B-cell crossmatch on renal transplantation: a multi-transplant center evaluation. Transplant Proc 1993: 25: 247.
18. THISTLETHWAITE JR JR, HEFFRON TG, STEVENS L, BUCKINGHAM M, STUART JK, STUART FP. The use of the T-cell flow cytometry crossmatch to evaluate the significance of positive B-cell serologic crossmatches in cadaveric donor renal transplantation. Transplant Proc 1990: 22: 1897.
19. LAZDA VA, POLLAK R, MOZES MF, JANASSON O. Positive B cell crossmatches in highly sensitized patients -influence of antibody specificity on renal transplant outcome. Transplant Proc 1987: 19: 782.
20. RUSS GR, NICHOLLS C, SHELDON A, HAY J. Positive B lymphocyte crossmatch and glomerular rejection in renal transplant recipients. Transplant Proc 1987: 19: 785.
21. AYOUB G, PARK MS, TERASAKI PI et al. B-cell antibodies and crossmatching. Transplantation 1980: 29: 227.
22. NOREEN HJ, VAN DER HAGEN E, BACH FH et al. Renal allograft survival in patients with positive donor-specific B lymphocyte crossmatches. Transplant Proc 1987: 19: 780.
23. SCORNIK JC, LEFOR WM, CICCIARELLI JC et al. Hyperacute and acute kidney graft rejection due to antibodies against B cells. Transplantation 1992: 54: 61.
24. SHROYER TW, CAGLE LR, DIETHEL MAG. A possible non-HLA antibody detected by flow cytometry crossmatch in the serum of a renal regraft recipient. Hum Immunol 1992: 34 (Suppl 1): 48. (Abstract).
25. SPERTINI F, CHATILA T, GEHA RS. Signals delivered via MHC class II molecules synergized with signals delivered via TCR/CD3 to cause proliferation and cytokine gene expression in T cells. J Immunol 1992: 149: 65.
26. MOURAD W, GEHA RS, CHATILA T. Engagement of major histocompatibility complex class II molecules induces sustained, lymphocyte function-associated molecule 1-dependent cell adhesion. J Exp Med 1990: 172: 1513.